# Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma

> **NCT04961138** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 164 (estimated)

## Conditions studied

- Hepatocellular Carcinoma Stage III

## Interventions

- **PROCEDURE:** Transhepatic Arterial Chemotherapy And Embolization (TACE)
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT04961138
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08
- **Primary completion:** 2022-12
- **Final completion:** 2023-03
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2021-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04961138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04961138, "Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT04961138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*